Stop the Cuts: Join the Effort to Protect Our Patients, Payments
Unless we persuade Congress to act, ophthalmologists could face significant Medicare cuts in 2022.
Related Articles
Mid-Year Forum 2024 Live Coverage
More than 400 ophthalmologists gather in Washington, D.C., for Mid-Year Forum 2024, April 17-20. Follow our ongoing coverage here.
Abstracts | Global Ophthalmology Summit
Learn how to submit your abstract for the Global Ophthalmology Summit
Gene Variants Linked to Glaucoma
A new study identified three gene variants that may be linked to why people of African descent are disproportionately affected by and blinded by glaucoma.
Mid-Year Forum 2024 Live Coverage
More than 400 ophthalmologists gather in Washington, D.C., for Mid-Year Forum 2024, April 17-20. Follow our ongoing coverage here.
Mid-Year Forum Overview – American Academy of Ophthalmology
During this Mid-Year Forum (MYF) in Washington, D.C., Academy members and other ophthalmic leaders gather to discuss critical issues facing ophthalmology
Intravitreal Ranibizumab Injection for ROP in Neonates
In this video, Dr. Rahul Bhatia and colleagues provide step-by-step instructions for injecting intravitreal ranibizumab in neonates with retinopathy of prematurity (ROP).
Copeland Fund Recipient a Longtime Advocacy Proponent
From speaking on racial disparities in medicine on the “Today” show to being recognized as the 2024 Robert J. Copeland Jr. Education Advocacy Fund recipient,…
Browse All Resident Content – American Academy of Ophthalmology
Access all the educational content for residents on the ONE Network, including cases and courses, flashcards, simulations, videos, and more.
Damage-Control Ophthalmology: Keeping the Ocular Ship From Sinking
When faced with complex ocular trauma, ophthalmologists may encounter factors that prevent them from rendering definitive care. A look at how ophthalmologists can overcome these…
Bimonthly Pegcetacoplan Is More Cost-Effective for Geographic Atrophy Than Monthly Treatment
A 2-year cost analysis suggests that long-term management of geographic atrophy with every-other-month pegcetacoplan may be more cost-effective than monthly treatment, though either option is…